In the validation cohort, total bilirubin (T-bil), ALP and gamma-glutamyl transpeptidase (γ-GTP) levels were significantly higher in CCA cases (p = 0.04, 0.01, 0.01; Supplementary Table S2). The gene discussed is GGTLC1; the disease is cholangiocarcinoma.